Carroll F I, Kotian P, Dehghani A, Gray J L, Kuzemko M A, Parham K A, Abraham P, Lewin A H, Boja J W, Kuhar M J
Research Triangle Institute, Research Triangle Park, North Carolina 27709.
J Med Chem. 1995 Jan 20;38(2):379-88. doi: 10.1021/jm00002a020.
Several 2 beta-carboxylic acid ester and amide analogues of cocaine and of 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid were prepared. The binding affinities of these compounds, and of some previously prepared analogues, at the dopamine (DA), norepinephrine (NE), and serotonin (5-HT) transporters were determined. The phenyl esters of 3 beta-(4'-methylphenyl)- and 3 beta-(4'-chlorophenyl)tropane-2 beta-carboxylic acid are highly potent and highly selective for the DA transporter. The isopropyl esters of 3 beta-(4'-chlorophenyl)- and 3 beta-(4'-iodophenyl)tropane-2 beta-carboxylic acid also possess high DA affinity and show significant DA transporter selectivity. Similarly, the phenyl and isopropyl ester analogues of cocaine are much more selective for the DA transporter than cocaine. Tertiary amide analogues of cocaine and of 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acids are more potent inhibitors of radioligand binding at the DA transporter than the primary and secondary amide analogues. In particular, 3 beta-(4'-chlorophenyl)tropane-2 beta-N-morpholinocarboxamide as well as the 3 beta-(4'-chlorophenyl)- and 3 beta-(4'-iodophenyl)tropane-2 beta-N- pyrrolidinocarboxamides possess high affinity and selectivity for the DA transporter. The N,N-dimethylamide cocaine analogue is the most selective cocaine amide derivative for the DA transporter. High correlation between the inhibition of radioligand binding and inhibition of uptake at the DA, NE, and 5-HT transporter was found for a selected group of analogues. Within this group, one compound, the isopropyl ester of 3 beta-(4'-iodophenyl)-tropane-2 beta-carboxylic acid, was found to be more potent in the inhibition of radioligand binding than in the inhibition of DA uptake. Taken together with its high potency and selectivity at the DA transporter, this suggests that this compound may be a lead in the development of a cocaine antagonist.
制备了可卡因以及3β-(4'-取代苯基)托烷-2β-羧酸的几种2β-羧酸酯和酰胺类似物。测定了这些化合物以及一些先前制备的类似物对多巴胺(DA)、去甲肾上腺素(NE)和5-羟色胺(5-HT)转运体的结合亲和力。3β-(4'-甲基苯基)-和3β-(4'-氯苯基)托烷-2β-羧酸的苯基酯对DA转运体具有高效力和高选择性。3β-(4'-氯苯基)-和3β-(4'-碘苯基)托烷-2β-羧酸的异丙酯也具有高DA亲和力并表现出显著的DA转运体选择性。同样,可卡因的苯基和异丙酯类似物对DA转运体的选择性比可卡因高得多。可卡因以及3β-(4'-取代苯基)托烷-2β-羧酸的叔酰胺类似物在DA转运体上对放射性配体结合的抑制作用比伯酰胺和仲酰胺类似物更强。特别是,3β-(4'-氯苯基)托烷-2β-N-吗啉甲酰胺以及3β-(4'-氯苯基)-和3β-(4'-碘苯基)托烷-2β-N-吡咯烷甲酰胺对DA转运体具有高亲和力和选择性。N,N-二甲基酰胺可卡因类似物是对DA转运体最具选择性的可卡因酰胺衍生物。对于一组选定的类似物,发现放射性配体结合抑制与DA、NE和5-HT转运体摄取抑制之间存在高度相关性。在该组中,发现一种化合物,即3β-(4'-碘苯基)托烷-2β-羧酸的异丙酯,在抑制放射性配体结合方面比抑制DA摄取更有效。结合其在DA转运体上的高效力和选择性,这表明该化合物可能是开发可卡因拮抗剂的先导化合物。